Marché mondial des emballages sous blister pharmaceutiques – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse et taille du marché

Au cours de la dernière décennie, le paysage du marché mondial a considérablement changé et cette période a été cruciale pour l'industrie pharmaceutique. Jusqu'au milieu des années 1990, les États-Unis, l'Europe et le Japon fournissaient 90 % des principes actifs pharmaceutiques (API) du monde. Cependant, au cours des dix dernières années, l'évolution des groupes de marché, les problèmes commerciaux et les bases de fabrication en mutation ont déplacé l'attention vers la région Asie-Pacifique. Selon une étude récente, la Chine fabrique plus de 40 % de tous les principes actifs pharmaceutiques dans le monde ; cependant, l'Inde et la Chine sont les principales sources, représentant plus de 75 % des importations d'API aux États-Unis.

• Le marché mondial des emballages sous blister pharmaceutiques était évalué à 6,55 milliards USD en 2021 et devrait atteindre 10,39 milliards USD d'ici 2029, enregistrant un TCAC de 5,60 % au cours de la période de prévision 2022-2029. Le « polychlorure de vinyle (PVC) » représente le segment de matériau le plus important sur le marché des emballages sous blister pharmaceutiques en raison de sa légèreté, de son faible coût, de ses excellentes propriétés de barrière et de sa nature inerte.

Définition du marché

L'emballage d'un produit pharmaceutique est un élément essentiel. L'emballage est fréquemment utilisé dans la distribution, le dosage et l'administration de produits pharmaceutiques. L'emballage sous blister est le type d'emballage le plus durable dans l'industrie pharmaceutique, car il protège divers produits pharmaceutiques de facteurs tels que l'air, l'humidité et la moisissure, qui peuvent provoquer une contamination s'ils entrent en contact avec eux. Il est très populaire car il protège les médicaments, améliore le respect du dosage et est facile à personnaliser pour s'adapter à la conception du produit.

Pharmaceutical Blister Packaging Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

• Growing Awareness Associated with Blister Packaging 

The blister packaging basically protects medication, improves dosage compliance, and can be easily customized to fit as per the product design, which is projected to accelerate the market's growth. The packaging protects various pharmaceutical products from factors including air, humidity, and moisture as contact of the products with these factors can lead to contamination, further boosting demand for the market.

• Development and Advancements

Furthermore, increase in product innovations, growing use of the smart packaging for patient engagement and identification and merger and acquisition to support new demands are other market growth determinants. Advanced manufacturing processes to develop sustainable and eco-friendly packaging solutions also extend profitable opportunities to the market players in the forecast period of 2022 to 2029.

The rising geriatric population and increasing incident of chronic conditions, pushing the demand for new and effective pharmaceutical products carve the way for market's expansion. Additionally, increase in patient-oriented medicines, including biologics will bolster the growth of the market. Surging urbanization, higher economic growth and improvements in the quality of life, will further expand the future growth of the pharmaceutical blister packaging market. 

Restraints/Challenges

• Price Volatility to Restrict Growth of Market

The price volatility of raw materials will create hindrances for the growth of the pharmaceutical blister packaging market.

• Stringent Government Regulations

The stringent government regulations and standard also challenge the pharmaceutical blister packaging market. Furthermore, the pandemic crisis results in lack of workforce, transportation restrictions, and shortage in raw materials and implementation of lockdown across the globe, which hampered the growth of market.

The lack of access and awareness in the emerging market is projected to hurdle the market's growth.

This pharmaceutical blister packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharmaceutical blister packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on Pharmaceutical Blister Packaging Market

The recent outbreak of coronavirus has critically impacted the various sectors across the globe. The materials and packaging sector was also grievously hit by the pandemic. The various lockdown and social distancing restrictions led to the large-scale disruptions in the supply chain, shortage of workers, transportation restrictions and raw material shortages resulting in downfall in the demand for pharmaceutical blister packaging.

However, the vaccines require different administration routes (e.g., inhaled, oral, transdermal, and injectable), demand for primary packaging can be extended across multiple packaging formats after vaccine approval. As a result, COVID-19 is expected to drive pharmaceutical packaging growth over the forecast period.

Recent Development

• In April 2020, Schott AG a German pharmaceutical glass manufacturer, introduced smart containers, which are laser-marked with a unique identifier to create robust traceability throughout the manufacturing process. The company has entered the digitised pharma manufacturing space. Every Smart Container is marked with a laser and a unique identifier, allowing for unprecedented traceability throughout the manufacturing process. The new concept allows pharma manufacturers to harness the power of machine vision and big data analytics on pharmaceutical filling lines. According to the German company, the new technology can be used to improve reject management and line clearance. It also lowers the chance of a mix-up, improves lyophilization processes, and facilitates container-based targeted recalls.

Global Pharmaceutical Blister Packaging Market Scope

The pharmaceutical blister packaging market is segmented on the basis of product type, technology type, material and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Clamshell
• Carded

On the basis of product type, the pharmaceutical blister packaging market has been segmented into clamshell and carded.

Technology Type

• Cold Forming
• Thermoforming

On the basis of technology type, the pharmaceutical blister packaging market has been segmented into cold forming and thermoforming.

Material

• Polyethylene Terephthalate,
• High Density Polyethylene (HDPE)
• Polyvinyl Chloride (PVC)
• Low Density Polyethylene (LDPE)
• Aluminum
• Paper and Paper Board

The pharmaceutical blister packaging market has also been segmented on the basis of material into polyethylene terephthalate, high density polyethylene (HDPE), polyvinyl chloride (PVC), low density polyethylene (LDPE), aluminum, paper and paper board. Polyethylene terephthalate includes PET, PETE, PETG or Polyester. Polyvinyl chloride (PVC) is the highest growing segment as compared to other materials as it the most popular raw material and is used owing to its light weight, low cost, excellent barrier properties and inert nature.

Application

• Tablets
• Capsules
• Powders
• Medical Devices

On the basis of application, the pharmaceutical blister packaging market is segmented into tablets, capsules, powders and medical devices.

Pharmaceutical Blister Packaging Market Regional Analysis/Insights

The pharmaceutical blister packaging market is analyzed and market size insights and trends are provided by country, product type, technology type, material and application as referenced above.

The countries covered in the pharmaceutical blister packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the pharmaceutical blister packaging market because of the presence of major pharmaceutical companies, availability of advanced technological research platforms and the increasing funding towards research and development.

On the other hand, Asia-Pacific is estimated to register a significant growth due to the increasing pharmaceutical production, a sizeable patient pool, rising consumer awareness, and the need for novel packaging materials.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces du porteur, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.   

Analyse du paysage concurrentiel et des parts de marché des emballages sous blister pharmaceutiques

Le paysage concurrentiel du marché des emballages sous blister pharmaceutiques fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination de l'application. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché des emballages sous blister pharmaceutiques.

Français Certains des principaux acteurs opérant sur le marché des emballages sous blister pharmaceutiques sont Schott (Allemagne), Amcor plc (Suisse), Dow (États-Unis), AptarGroup, Inc., (États-Unis), Klöckner Pentaplast (Allemagne), West Pharmaceutical Services, Inc. (États-Unis), Berry Global Inc. (États-Unis), Honeywell International, Inc. (États-Unis), ACG (Inde), Nipro (Japon), Gerresheimer AG (Allemagne), Catalent Inc., (États-Unis) et WestRock Company (États-Unis) entre autres.

SKU-54511